6:25 PM
 | 
Dec 12, 2012
 |  BC Extra  |  Company News

FDA to review depression therapy from Takeda, Lundbeck

H. Lundbeck A/S (CSE:LUN) and partner Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >